BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 29502284)

  • 1. Fertility preservation for female cancer patients.
    Harada M; Osuga Y
    Int J Clin Oncol; 2019 Jan; 24(1):28-33. PubMed ID: 29502284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fertility preservation in adolescents and young adults with cancer].
    Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C
    Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility sparing in cancer patients.
    Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
    Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients.
    Hulsbosch S; Koskas M; Tomassetti C; De Sutter P; Wildiers H; Neven P; D'Hooghe T; Amant F
    Gynecol Obstet Invest; 2018; 83(2):156-163. PubMed ID: 29050014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where are oncofertility and fertility preservation treatments heading in 2016?
    Harada M; Osuga Y
    Future Oncol; 2016 Oct; 12(20):2313-21. PubMed ID: 27328888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of cryopreservation of ovarian tissue for fertility preservation in cancer patients].
    Gamzatoval ZKh; Komlichenko EV; Kostareva AA; Galagudza MM; Berlev IV; Urmancheeva AF; Ulrikh EA; Malashicheva AB; Belyakova MV; Molotkova MY
    Vopr Onkol; 2015; 61(2):199-204. PubMed ID: 26087598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in fertility preservation and counseling for female cancer patients.
    Dolmans MM
    Expert Rev Anticancer Ther; 2018 Feb; 18(2):115-120. PubMed ID: 29220203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation in pediatric, adolescent and young adult female cancer patients.
    Ayensu-Coker L; Bauman D; Lindheim SR; Breech L
    Pediatr Endocrinol Rev; 2012 Nov; 10(1):174-87. PubMed ID: 23469394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
    Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
    Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy.
    Fabi A; Lanzetta G; Vizza E; Corsi D; Moscetti L; Spinelli G; Mentuccia L; Lalle M; Perrone M; Baiocco L; Falcicchio C; Milani A; Giannarelli D; Cognetti F; Pugliese P
    Curr Probl Cancer; 2019 Dec; 43(6):100479. PubMed ID: 31126661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.
    Dolmans MM; Donnez J
    Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fertility preservation in oncology].
    Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
    Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients.
    Lee S; Ozkavukcu S; Ku SY
    Reprod Sci; 2021 Jun; 28(6):1746-1758. PubMed ID: 33791995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F
    Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F;
    Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.